Ponazuril is a triazine-based anticoccidial and antiprotozoal agent. It is the active metabolite of toltrazuril and is FDA-approved for horses under the brand name Marquis for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. In reptile medicine, ponazuril has become an important drug for treating coccidiosis (caused by Isospora and other coccidia) and is also used off-label for cryptosporidiosis. Ponazuril works by inhibiting the mitochondrial enzymes of protozoan parasites, disrupting their energy metabolism and reproductive cycle.
Overview
Coccidiosis is one of the most common parasitic infections in captive reptiles, particularly in bearded dragons, leopard geckos, and chameleons. Coccidia are intracellular protozoan parasites that invade the intestinal lining, causing diarrhea, weight loss, dehydration, and potentially death in heavily infected or immunocompromised animals. Ponazuril has largely replaced older coccidiostats like sulfadimethoxine in many reptile practices because it is coccidiocidal (kills the parasite) rather than merely coccidiostatic (stops reproduction but does not kill).
In horses, EPM is a serious neurological disease caused by Sarcocystis neurona (and less commonly Neospora hughesi). Ponazuril is one of the primary FDA-approved treatments.
Temperature and reptile pharmacology: As with all drugs used in reptiles, ambient temperature affects drug metabolism. Reptiles maintained at their preferred optimum temperature zone (POTZ) will metabolize ponazuril at the expected rate. Suboptimal temperatures slow metabolism and may affect drug efficacy and clearance.
Uses
Reptiles
- Coccidiosis — Isospora amphiboluri in bearded dragons, Isospora spp. in other lizard species, coccidia in snakes and chelonians
- Cryptosporidiosis — Cryptosporidium serpentis in snakes, C. varanii in lizards; evidence of efficacy is limited but ponazuril is one of few treatment options
- Other protozoal infections — Off-label use for various intracellular protozoa
Horses
- Equine protozoal myeloencephalitis (EPM) — FDA-approved indication; caused by Sarcocystis neurona
- Coccidiosis in foals — Off-label use for intestinal coccidiosis
Dosage
Your veterinarian will determine the exact dose and duration. Dosing varies significantly between species.
Reptiles
| Species / Condition | Typical Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Bearded dragons (coccidiosis) | 20-50 mg/kg | Oral | Every 24-48 hours | 3-5 days, repeat in 2 weeks |
| Other lizards (coccidiosis) | 20-30 mg/kg | Oral | Every 24-48 hours | Variable |
| Snakes (cryptosporidiosis) | 5-20 mg/kg | Oral | Every 24-48 hours | Prolonged courses (weeks) |
| Chelonians (coccidiosis) | 20-30 mg/kg | Oral | Every 24-48 hours | 3-5 days, repeat in 2 weeks |
Horses
| Indication | Typical Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| EPM (S. neurona) | 5 mg/kg | Oral | Once daily | 28 days |
| Coccidiosis (foals) | 20 mg/kg | Oral | Once, repeat in 7-14 days | 1-2 treatments |
Administration Notes
- Ponazuril is given orally — it is well absorbed from the GI tract.
- In reptiles, it can be administered via oral syringe directly into the mouth or via stomach tube for uncooperative patients.
- The Marquis paste (horse formulation) can be diluted for use in reptiles; compounding pharmacies also prepare reptile-appropriate concentrations.
- Ensure proper hydration during treatment, particularly in reptiles with diarrhea from coccidiosis.
- Maintain reptiles at their POTZ throughout treatment.
Side Effects
| Common Side Effects | Serious Side Effects (Contact Your Vet) |
|---|---|
| Mild decreased appetite | Severe lethargy |
| Soft stool (transient) | Prolonged anorexia |
| Mild lethargy during treatment | Signs of hepatic stress (rare) |
| Worsening diarrhea or dehydration |
Ponazuril is generally well-tolerated in both reptiles and horses. Side effects are uncommon at recommended doses.
Horses — Additional Side Effects
- Mild skin reactions (urticaria) — uncommon
- Loose stool
- Rarely, neurological signs may transiently worsen at the start of EPM treatment as parasites die (inflammatory response)
Drug Interactions
- No major drug interactions are well-documented for ponazuril in reptiles or horses.
- Use caution when combining with other hepatically metabolized drugs, as ponazuril undergoes liver metabolism.
- Can be used concurrently with supportive therapies (fluids, nutritional support, probiotics) without interaction.
Contraindications
- Known hypersensitivity to ponazuril or toltrazuril
- Use with caution in animals with hepatic (liver) disease — ponazuril is metabolized by the liver
- Pregnant animals — safety not established in pregnant reptiles or horses; use only if benefits outweigh risks
- Not a substitute for proper husbandry — coccidiosis in reptiles is often associated with overcrowding, stress, and poor sanitation. Environmental management is essential alongside drug treatment.
Storage
- Store at controlled room temperature, 59-86degF (15-30degC).
- Do not freeze.
- Marquis paste: use within the timeframe specified by the manufacturer once opened.
- Compounded suspensions: follow the beyond-use date provided by the compounding pharmacy (typically 30-90 days refrigerated).
Frequently Asked Questions
Why is my bearded dragon being treated with a horse medication? Ponazuril (Marquis) is FDA-approved for horses, but it is widely used off-label in reptile medicine for coccidiosis. Veterinarians commonly use drugs approved in one species to treat others when there is good evidence of safety and efficacy. Your veterinarian will adjust the dose appropriately for your reptile.
Will ponazuril cure cryptosporidiosis in my snake? Cryptosporidiosis in reptiles is notoriously difficult to treat, and no drug has been proven to reliably eliminate Cryptosporidium in snakes. Ponazuril is one of several drugs that have shown some promise, and it may reduce parasite burden and improve clinical signs, but a complete cure is not guaranteed. Discuss realistic expectations with your veterinarian.
Does my bearded dragon need a second treatment? Often, yes. Coccidia have a complex life cycle with stages that may not be susceptible to ponazuril. A second treatment course 2 weeks after the first targets newly emerged parasites and increases the likelihood of eliminating the infection. Follow your veterinarian’s instructions regarding retreatment.
Should I clean my reptile’s enclosure during treatment? Absolutely. Coccidia shed environmentally resistant oocysts in feces. During and after treatment, thoroughly clean and disinfect the enclosure, remove all feces promptly, and minimize fecal-oral reinfection. Steam cleaning or ammonia-based disinfection (with thorough rinsing) is more effective against oocysts than many standard disinfectants.
Always consult a veterinarian experienced with reptiles or horses before using ponazuril. Accurate diagnosis through fecal examination is essential before starting antiprotozoal therapy.
Sources & References
- Carpenter JW. Exotic Animal Formulary, 6th Edition. Elsevier.
- Divers SJ, Stahl SJ. Mader’s Reptile and Amphibian Medicine and Surgery, 3rd Edition. Elsevier.
- Merck Veterinary Manual - Anticoccidial Agents
- MacNeill AL, et al. Treatment of coccidiosis in reptiles. Journal of Herpetological Medicine and Surgery.
- FDA Marquis (ponazuril) label information.